KLCM Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
+552
New +$205K 0.02% 275
2025
Q3
Sell
-551
Closed -$214K 182
2025
Q2
$214K Hold
551
0.02% 154
2025
Q1
$240K Hold
551
0.03% 149
2024
Q4
$203K Hold
551
0.02% 158
2024
Q3
$287K Hold
551
0.03% 133
2024
Q2
$299K Hold
551
0.04% 129
2024
Q1
$286K Hold
551
0.04% 130
2023
Q4
$260K Buy
+551
New +$255K 0.04% 124

Other funds holding ELV

KLCM Advisors's ELV Position: Q2 2026 in Review

KLCM Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 552 shares worth $214K. The stake represents 0.02% of the portfolio and ranks #275 among its holdings. This is a return to the name: KLCM Advisors previously reported a position in ELV as recently as Q2 2025.

KLCM Advisors first reported a position in ELV in Q4 2023 and has held it in 8 quarters since. The position peaked at $299K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • KLCM Advisors held 552 shares of Elevance Health worth $214K as of Q2 2026.
  • Elevance Health was a new KLCM Advisors position in Q2 2026.
  • Elevance Health made up 0.02% of KLCM Advisors's portfolio in Q2 2026, its #275 holding.
  • KLCM Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 8 quarters since.
  • KLCM Advisors's Elevance Health position peaked at $299K in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.